A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

NCT05421858 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Candidemia
Candidiasis, Invasive

Interventions

DRUG: Fosmanogepix
DRUG: Fosmanogepix
DRUG: Caspofungin
DRUG: Fluconazole
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo

Sponsor

Basilea Pharmaceutica

Collaborators

[object Object]